14.1 C
Delhi
Monday, February 10, 2025

Djokovic has 80% share in biotech firm developing Covid treatment – report

Serbian tennis star Novak Djokovic has an 80% stake in Danish biotech company QuantBioRes, its chief executive says

Novak Djokovic holds a majority stake in a Danish biotech company which is aiming to develop a medical treatment to combat coronavirus, the firm’s chief executive has said.

QuantBioRes CEO Ivan Loncarevic revealed the news to Reuters on Wednesday, explaining that the Serbian star has an 80% share. 

Loncarevic said the tennis world number one – who has amassed over $150 million in career prize money – made the investment in June 2020, but did not disclose the amount.

Copenhagen-based QuantiBioRes is aiming to develop a ‘peptide’ treatment against Covid-19 which would inhibit the virus from infecting human cells.

Read more

Novak Djokovic is back in Serbia after being deported from Australia. © Getty Images
Tennis Australia finally issues statement on Djokovic debacle – with one glaring omission

It expects to launch clinical trials in the UK later this year, and has around a dozen researchers working in Denmark, Australia, and Slovenia, Loncarevic explained.

The CEO stressed that it was a treatment against the illness, rather than a vaccine.  

The news comes after Djokovic was deported from Australia in a row centered on his Covid vaccine status.

The 34-year-old star is not vaccinated against the illness but arrived in Australia with a medical exemption based on recovery from a prior infection in December.

However, that was deemed insufficient by the federal authorities.

After an ordeal lasting almost two weeks, Djokovic was eventually deported following the intervention of Australian Immigration Minister Alex Hawke, who argued that the Serb’s continued presence in the country would incite anti-vaccine sentiments among the local population.


READ MORE: Will Novak Djokovic be barred from other Grand Slams?

https://ift.tt/3runhNu 19, 2022 at 11:01PM
from RT – Daily news

Most Popular Articles